<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> may exhibit histopathologic features similar to those of a newly emerging clinical entity, immunoglobulin G4-related sclerosing disease, <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> is currently not considered to be associated with immunoglobulin G4-related immunoinflammation </plain></SENT>
<SENT sid="1" pm="."><plain>Not many studies on this association have been reported </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated serum immunoglobulin G4 levels among patients with <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> with or without cardiac involvement (<z:e sem="disease" ids="C0392077" disease_type="Disease or Syndrome" abbrv="">cardiac sarcoidosis</z:e> and non-<z:e sem="disease" ids="C0392077" disease_type="Disease or Syndrome" abbrv="">cardiac sarcoidosis</z:e> patients) </plain></SENT>
<SENT sid="3" pm="."><plain>The mean serum immunoglobulin G4 level among the 65 patients with <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> was 56.8 ± 43.0 mg/dL, which did not significantly differ between patients with <z:e sem="disease" ids="C0392077" disease_type="Disease or Syndrome" abbrv="">cardiac sarcoidosis</z:e> (54 ± 48 mg/dL, n = 12) and patients without <z:e sem="disease" ids="C0392077" disease_type="Disease or Syndrome" abbrv="">cardiac sarcoidosis</z:e> (58 ± 42 mg/dL; n = 53) </plain></SENT>
<SENT sid="4" pm="."><plain>Serum level of soluble interleukin 2 receptor, a potent marker that may reflect <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> activity, was elevated in <z:e sem="disease" ids="C0392077" disease_type="Disease or Syndrome" abbrv="">cardiac sarcoidosis</z:e> (910 ± 683 U/L) and noncardiac <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> (689 ± 399 U/L) but did not significantly differ between the groups </plain></SENT>
<SENT sid="5" pm="."><plain>Immunohistochemistry of cardiac or lymph node specimens from patients with <z:e sem="disease" ids="C0392077" disease_type="Disease or Syndrome" abbrv="">cardiac sarcoidosis</z:e> showed only sparse or no infiltration of immunoglobulin G4-positive lymphocytes, in contrast to the moderate to severe infiltration of CD68-positive macrophages and CD45-positive lymphocytes </plain></SENT>
<SENT sid="6" pm="."><plain>Although the number of study subjects was small, these findings collectively suggest that regardless of the presence or absence of cardiac involvement, <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> does not belong to or overlap with immunoglobulin G4-related sclerosing disease </plain></SENT>
</text></document>